Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U-BioMed is a South Korean medical device and biotechnology company specializing in advanced drug delivery systems and high-functional cosmetics. Founded in 2009, the company is globally recognized for its proprietary "Tappy Tok Tok" platform, a painless microneedle device designed to deliver nutrients and medications directly through the skin's barrier via a unique tapping motion. Their product portfolio spans medical aesthetics, hair regrowth treatments, and professional skin care solutions. U-BioMed also operates as an OEM/ODM manufacturer for bio-cosmetic products, leveraging their patented micro-structure technology. Beyond aesthetics, the company is actively researching medical applications for its delivery system, including transdermal vaccine and insulin delivery. They maintain a global presence, exporting to numerous markets in Asia, Europe, and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U-BioMed.